Tag Archives: Crohn’s disease

October, 2018

September, 2018

June, 2018

January, 2018

  • 5 January

    Takeda Announces Intention to Acquire Cell Therapy Firm TiGenix

    Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today announced its intention to acquire TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”), an advanced biopharmaceutical company developing novel stem cell therapies for serious medical conditions, and as a result has entered into an offer and support agreement with TiGenix which provides …

December, 2017

  • 15 December

    FDA Approves Pfizer’s Ixifi, a Biosimilar to Remicade

    Pfizer Inc. (NYSE:PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) has approved IXIFI™ (PF-06438179, infliximab-qbtx), a chimeric human-murine monoclonal antibody (mAb) against tumor necrosis factor, as a biosimilar to Remicade® (infliximab)* for all eligible indications of the reference product.1 The FDA has approved IXIFI as …

October, 2017